Literature DB >> 18318111

Development of vaccine strains of H5 and H7 influenza viruses.

Kosuke Soda1, Yoshihiro Sakoda, Norikazu Isoda, Masahiro Kajihara, Yoshinari Haraguchi, Hitomi Shibuya, Hiromi Yoshida, Takashi Sasaki, Ryuichi Sakamoto, Kazue Saijo, Junko Hagiwara, Hiroshi Kida.   

Abstract

To establish vaccine strains of H5 and H7 influenza viruses, A/duck/Hokkaido/Vac-1/04 (H5N1) [Vac-1/04 (H5N1)], A/duck/Hokkaido/Vac-3/07 (H5N1) [Vac-3/07 (H5N1)], and A/duck/Hokkaido/ Vac-2/04 (H7N7) [Vac-2/04 (H7N7)] were generated from non-pathogenic avian influenza viruses isolated from migratory ducks. Vac-1/04 (H5N1) and Vac-3/07 (H5N1) were generated by genetic reassortment between H5N2 or H5N3 virus as an HA gene provider and H7N1 or H6N1 viruses as an NA gene provider. Vac-2/04 (H7N7) was a genetic reassortant obtained using H7N7 and H9 N2 viruses to give high growth character of the H9N2 virus in chicken embryonated eggs. The results of sequence analyses and experimental infections revealed that these H5N1 and H7N7 reassortant viruses were non-pathogenic in chickens and embryos, and had good growth potential in embryonated eggs. These viruses should be useful to develop vaccines against H5 and H7 highly pathogenic avian influenza viruses.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18318111

Source DB:  PubMed          Journal:  Jpn J Vet Res        ISSN： 0047-1917            Impact factor:   0.649


  20 in total

1.  Biological and protective properties of immune sera directed to the influenza virus neuraminidase.

Authors:  Stefan J Halbherr; Thomas H Ludersdorfer; Meret Ricklin; Samira Locher; Marianne Berger Rentsch; Artur Summerfield; Gert Zimmer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Hemagglutinin-dependent tropism of H5N1 avian influenza virus for human endothelial cells.

Authors:  Manuela Ocaña-Macchi; Michael Bel; Laurence Guzylack-Piriou; Nicolas Ruggli; Matthias Liniger; Kenneth C McCullough; Yoshihiro Sakoda; Norikazu Isoda; Mikhail Matrosovich; Artur Summerfield
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

3.  An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.

Authors:  Ahmad M Haredy; Nobuyuki Takenaka; Hiroshi Yamada; Yoshihiro Sakoda; Masatoshi Okamatsu; Naoki Yamamoto; Takeshi Omasa; Hisao Ohtake; Yasuko Mori; Hiroshi Kida; Koichi Yamanishi; Shigefumi Okamoto
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

4.  Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2.

Authors:  Matthias Liniger; Artur Summerfield; Gert Zimmer; Kenneth C McCullough; Nicolas Ruggli
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

5.  High interferon type I responses in the lung, plasma and spleen during highly pathogenic H5N1 infection of chicken.

Authors:  Hervé R Moulin; Matthias Liniger; Sylvie Python; Laurence Guzylack-Piriou; Manuela Ocaña-Macchi; Nicolas Ruggli; Artur Summerfield
Journal:  Vet Res       Date:  2011-01-11       Impact factor: 3.683

6.  H9N2 influenza virus acquires intravenous pathogenicity on the introduction of a pair of di-basic amino acid residues at the cleavage site of the hemagglutinin and consecutive passages in chickens.

Authors:  Kosuke Soda; Shingo Asakura; Masatoshi Okamatsu; Yoshihiro Sakoda; Hiroshi Kida
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

7.  Characterization of a non-pathogenic H5N1 influenza virus isolated from a migratory duck flying from Siberia in Hokkaido, Japan, in October 2009.

Authors:  Naoki Yamamoto; Yoshihiro Sakoda; Masayuki Motoshima; Fumi Yoshino; Kosuke Soda; Masatoshi Okamatsu; Hiroshi Kida
Journal:  Virol J       Date:  2011-02-11       Impact factor: 4.099

8.  Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.

Authors:  Stefan J Halbherr; Terza Brostoff; Merve Tippenhauer; Samira Locher; Marianne Berger Rentsch; Gert Zimmer
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

9.  Isolation of recombinant phage antibodies targeting the hemagglutinin cleavage site of highly pathogenic avian influenza virus.

Authors:  Jinhua Dong; Akira Sakurai; Namiko Nomura; Enoch Y Park; Futoshi Shibasaki; Hiroshi Ueda
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens.

Authors:  Matthias Liniger; Artur Summerfield; Nicolas Ruggli
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.